Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Does Leckrone benefit from a weak PTSC?

I humbly refer you to the following, and should clarification be needed suggest it is sought from those who profess greater legal knowledge:

On August 13, 2010 the Court provisionally allowed some file redactions pursuant to a Motion filed by TPL and will decide the appropriateness of those redactions on September 30, 2010.

It is significant, in my very humble opinion.

.

.

.

Be well

Share
New Message
Please login to post a reply